Repare Therapeutics Inc expected to post a loss of 60 cents a share - Earnings Preview

Repare Therapeutics

09/08/2021 12:12

* Repare Therapeutics Inc  RPTX.OQ   RPTX.O  is expected to show
a rise in quarterly revenue when it reports results on August 11
(estimated). 
* The St-laurent, Quebec-based company is expected to report
revenue of $600 thousand, according to the mean estimate from 5
analysts, based on Refinitiv data.  
​* Refinitiv's mean analyst estimate for Repare Therapeutics Inc
is for a loss of 60 cents per share. For the same quarter last
year, the company reported a loss of $2.45 per share.
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 7 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
* The mean earnings estimate of analysts was unchanged in the
last three months. ​
* Wall Street's median 12-month price target for Repare
Therapeutics Inc is $46​, about 26% above​ its last closing
price of $34.05. ​​​
* Previous quarterly performance (using preferred earnings
measure in US dollars). ​
 QUARTER       STARMINE    REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        SMARTESTIM  IBES                 MET,    SE %
               ATE®        ESTIMATE             MISSED  
 Mar. 31 2021  -0.51       -0.51      -0.58     Missed  -14.6
 Dec. 31 2020  -0.40       -0.39      -0.41     Missed  -3.8
 Sep. 30 2020  -0.39       -0.38      -0.37     Beat    2.2​
 Jun. 30 2020  -0.05       -0.06      -2.45     Missed  -4,160
                                                        .9
 ​​            ​                                        ​
                                                        ​
 This summary was machine generated August 9 at 11:12 GMT.  All
figures in US dollars unless otherwise stated